Literature DB >> 19065231

Optimizing distance image quality of an aspheric multifocal intraocular lens using a comprehensive statistical design approach.

Xin Hong1, Xiaoxiao Zhang.   

Abstract

The AcrySof ReSTOR intraocular lens (IOL) is a multifocal lens with state-of-the-art apodized diffractive technology, and is indicated for visual correction of aphakia secondary to removal of cataractous lenses in adult patients with/without presbyopia, who desire near, intermediate, and distance vision with increased spectacle independence. The multifocal design results in some optical contrast reduction, which may be improved by reducing spherical aberration. A novel patent-pending approach was undertaken to investigate the optical performance of aspheric lens designs. Simulated eyes using human normal distributions were corrected with different lens designs in a Monte Carlo simulation that allowed for variability in multiple surgical parameters (e.g. positioning error, biometric variation). Monte Carlo optimized results indicated that a lens spherical aberration of -0.10 microm provided optimal distance image quality.

Entities:  

Mesh:

Year:  2008        PMID: 19065231     DOI: 10.1364/oe.16.020920

Source DB:  PubMed          Journal:  Opt Express        ISSN: 1094-4087            Impact factor:   3.894


  3 in total

1.  Impact of pupil transmission apodization on presbyopic through-focus visual performance with spherical aberration.

Authors:  Len Zheleznyak; HaeWon Jung; Geunyoung Yoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-03       Impact factor: 4.799

2.  Comparison of retinal image quality with spherical and customized aspheric intraocular lenses.

Authors:  Huanqing Guo; Alexander V Goncharov; Chris Dainty
Journal:  Biomed Opt Express       Date:  2012-03-01       Impact factor: 3.732

3.  Optical bench performance of a novel trifocal intraocular lens compared with a multifocal intraocular lens.

Authors:  Shinwook Lee; Myoung Choi; Zaiwei Xu; Zeyu Zhao; Elsinore Alexander; Yueai Liu
Journal:  Clin Ophthalmol       Date:  2016-06-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.